Published Apr 1, 2024

Benefits & Risks of Peptide Therapeutics for Physical & Mental Health

Andrew Huberman dives into peptide therapeutics, revealing their pivotal role in tissue repair, metabolism, and vitality while highlighting the promising yet cautious landscape of growth hormone peptides and their impact on longevity and health.
Episode Highlights
Huberman Lab logo

Popular Clips

Questions from this episode

Episode Highlights

  • Types & Effects

    Growth hormone peptides are categorized into two main types, each with distinct mechanisms and effects. explains that type one peptides, like sermorelin and tessamorelin, are FDA-approved and used off-label to increase growth hormone and IGF-1 levels, enhancing metabolism and muscle growth 1. Type two peptides, such as ipamorelin and hexarelin, stimulate growth hormone release by increasing ghrelin, which can also elevate hunger and anxiety 2. These peptides can improve sleep by boosting deep sleep, although their impact on REM sleep remains uncertain 2.

    Growth hormone potently increases ATP production, which is involved in energy and metabolism in our cells, and as a consequence, our overall feelings of energy to just do things mental or physical.

    ---

    Huberman emphasizes the importance of working with knowledgeable professionals when using these peptides to avoid adverse effects and ensure proper dosing 1.

       

    Risks & Benefits

    The use of growth hormone peptides comes with both potential benefits and significant risks. highlights that while these peptides can enhance vitality, muscle growth, and fat loss, they also pose risks such as tumor growth and receptor desensitization 3. The peptides can cause changes in body structure and increase cancer risk due to their indiscriminate tissue growth promotion 3. Despite these risks, many are drawn to the peptides for their ability to accelerate recovery and improve physical appearance 4.

    There are, of course, risks to taking anything, but in particular to exploring augmentation of the growth hormone pathway.

    ---

    Huberman advises caution, especially for those under 30, and stresses the importance of using minimal effective doses to mitigate potential adverse effects 3.

Related Episodes